Study shows PRRS vaccine can provide protection against challenge with HP-PRRSV
Immune response, IL-10 and protective efficacy against a single HP-PRRSV challenge or in conjunction with PRRSV1 of pigs intradermally and intramuscularly vaccinated with modified live PRRSV1.
5 November 2019
3 minute read
By: 
Porcine interleukin-10 (IL-10) concentration in cell culture supernatants of stimulated PBMC with vaccine virus. Values are expressed as mean±SEM. Different letters indicate statistical (P<0.05) differences among groups.
PRRSV-specific IFN-γ-producing cells (IFN-γ-PC) in stimulated PBMC with: (A) homologous virus; (B) heterologous type 1 PRRSV (AN06EU4204); and (C) heterologous type 2 PRRSV (FDT10US23). Values are expressed as mean±SEM. Different letters indicate statistical (P<0.05) differences among groups.
| References | ||||
|---|---|---|---|---|
| 1. Nilubol et al. | ||||
| (2013) | . Arch Virol | 158(5):943-53 |
Madapong, A.
Department of Veterinary Microbiology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand
Tantituvanont, A.
Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand
Nilubol, D.
Department of Veterinary Microbiology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand
